<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2019-1-190-200</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-2183</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL PAPERS</subject></subj-group></article-categories><title-group><article-title>Иммунофенотип макрофагальной популяции при фиброзно-кавернозном туберкулезе легких</article-title><trans-title-group xml:lang="en"><trans-title>Immunophenotype of the macrophage population in fibrous, cavernous pulmonary tuberculosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3917-924X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голубинская</surname><given-names>Е. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Golubinskaya</surname><given-names>E. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Голубинская Елена Петровна, кандидат медицинских наук, доцент, кафедра патологической анатомии с секционным курсом</p><p>Крымский федеральный университет (КФУ) имени В.И. Вернадского</p><p>Республика Крым, 295051, г. Симферополь, бульвар Ленина, 5/7</p><p> </p></bio><bio xml:lang="en"><p>Golubinskaya Elena P., PhD, Associate Professor, Department of Pathological Anatomy with Sectional Course</p><p>Crimean Federal University (СFU) named after Vernadsky</p><p>5/7, Lenin Blv., Simferopol, 295051, Republic of Crimea</p></bio><email xlink:type="simple">missive@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4674-7391</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Филоненко</surname><given-names>Т. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Filonenko</surname><given-names>T. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Филоненко Татьяна Григорьевна, кандидат медицинских наук, доцент, кафедра патологической анатомии с секционным курсом</p><p>Крымский федеральный университет (КФУ) имени В.И. Вернадского</p><p>Республика Крым, 295051, г. Симферополь, бульвар Ленина, 5/7 </p></bio><bio xml:lang="en"><p>Filonenko Tatyana G., PhD, Associate Professor, Department of Pathological Anatomy with Sectional Course</p><p>Crimean Federal University (СFU) named after Vernadsky</p><p>5/7, Lenin Blv., Simferopol, 295051, Republic of Crimea</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1309-4005</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кубышкин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kubyshkin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кубышкин Анатолий Владимирович, доктор медицинских наук, профессор, заведующий кафедрой общей и клинической патофизиологии</p><p>Крымский федеральный университет (КФУ) имени В.И. Вернадского</p><p>Республика Крым, 295051, г. Симферополь, бульвар Ленина, 5/7</p></bio><bio xml:lang="en"><p>Kubyshkin Anatoly V., DM, Professor, Head of the General and Clinical Pathophysiology Department</p><p>Crimean Federal University (СFU) named after Vernadsky</p><p>5/7, Lenin Blv., Simferopol, 295051, Republic of Crimea</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4474-3714</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ермола</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yermola</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ермола Юлианна Аркадьевна, кандидат медицинских  наук, доцент, кафедра патологической анатомии с секционным курсом</p><p>Крымский федеральный университет (КФУ) имени В.И. Вернадского</p><p>Республика Крым, 295051, г. Симферополь, бульвар Ленина, 5/7</p></bio><bio xml:lang="en"><p>YermolaYulianna A., PhD, Associate Professor, Department of Pathological Anatomy with Sectional Course</p><p>Crimean Federal University (СFU) named after Vernadsky</p><p>5/7, Lenin Blv., Simferopol, 295051, Republic of Crimea</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7179-3402</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кальфа</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalfa</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кальфа Маргарита Алексеевна, ассистент, кафедра патологической анатомии с секционным курсом</p><p>Крымский федеральный университет (КФУ) имени В.И. Вернадского</p><p>Республика Крым, 295051, г. Симферополь, бульвар Ленина, 5/7</p></bio><bio xml:lang="en"><p>Kalfa Margarita A., Assistant, Department of Pathological Anatomy with Sectional Course</p><p>Crimean Federal University (СFU) named after Vernadsky</p><p>5/7, Lenin Blv., Simferopol, 295051, Republic of Crimea</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5076-2570</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Геращенко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gerashchenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Геращенко Алина Витальевна, ассистент, кафедра патологической анатомии с секционным курсом</p><p>Крымский федеральный университет (КФУ) имени В.И. Вернадского</p><p>Республика Крым, 295051, г. Симферополь, бульвар Ленина, 5/7</p></bio><bio xml:lang="en"><p>Gerashenko Alina V., Assistant, Department of Pathological Anatomy with Sectional Course</p><p>Crimean Federal University (СFU) named after Vernadsky</p><p>5/7, Lenin Blv., Simferopol, 295051, Republic of Crimea</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2632-0451</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крамарь</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kramar</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Крамарь Татьяна Вадимовна, студент</p><p>Крымский федеральный университет (КФУ) имени В.И. Вернадского</p><p>Республика Крым, 295051, г. Симферополь, бульвар Ленина, 5/7</p></bio><bio xml:lang="en"><p>Kramar Tatyana V., Student</p><p>Crimean Federal University (СFU) named after Vernadsky</p><p>5/7, Lenin Blv., Simferopol, 295051, Republic of Crimea</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Медицинская академия имени С.И. Георгиевского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Medical Academy named after S.I. Georgievsky</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>16</day><month>05</month><year>2019</year></pub-date><volume>18</volume><issue>1</issue><fpage>190</fpage><lpage>200</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Голубинская Е.П., Филоненко Т.Г., Кубышкин А.В., Ермола Ю.А., Кальфа М.А., Геращенко А.В., Крамарь Т.В., 2019</copyright-statement><copyright-year>2019</copyright-year><copyright-holder xml:lang="ru">Голубинская Е.П., Филоненко Т.Г., Кубышкин А.В., Ермола Ю.А., Кальфа М.А., Геращенко А.В., Крамарь Т.В.</copyright-holder><copyright-holder xml:lang="en">Golubinskaya E.P., Filonenko T.G., Kubyshkin A.V., Yermola Y.A., Kalfa M.A., Gerashchenko A.V., Kramar T.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/2183">https://bulletin.ssmu.ru/jour/article/view/2183</self-uri><abstract><sec><title>Цель исследования</title><p>Цель исследования: изучение иммунофенотипа макрофагальной популяции и механизмов их векторного перераспределения при фиброзно-кавернозном туберкулезе легких.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Материалом для исследования явились фрагменты стенки каверны и перикавернозной легочной ткани прооперированных по поводу фиброзно-кавернозного туберкулеза (ФКТ) легких (n = 163). Все пациенты были разделены на две основные группы (с активным бактериовыделением (МБТ+, n = 84) и клиническим абациллированием (МБТ–, n = 79)) для проведения иммуногистохимического исследования с панелью маркеров: макрофагов и гистиоцитов – CD68; сосудистого фактора роста А – VEGF-A; Т-хелперов CD4, цитотоксических Т-лимфоцитов CD8.</p></sec><sec><title>Результаты</title><p>Результаты. При анализе экспрессии маркера CD68 установлена популяционная неоднородность макрофагов в зависимости от интенсивности цитоплазматической реакции функциональной активности с различными локализационными и количественными характеристиками: высокоактивные (тип 1), умеренно активные (тип 2) и слабоактивные (тип 3). На основании реакции с сосудистым фактором ростом A определено, что клетки VEGF+ соответствуют слабоактивным макрофагам CD68+ и локализуются на границе перехода специфической грануляционной ткани в фиброзный слой, перикавернозной зоне и интактной легочной ткани со статистически значимым преобладанием у пациентов с МБТ– (р &lt; 0,05). Независимо от активности бактериовыделения число клеток VEGF+ в зоне лимфоидных фолликулов прямо коррелирует с количеством макрофагов CD68+ в перикавернозной зоне (R = 0,68) и обратно – с числом VEGF+ диффузно рассеянных клеток в фиброзной капсуле (R = макрофагов 0,75). При этом CD68+/VEGF+ визуализируются в зоне CD8+ Т-лимфоцитов, а CD68+/VEGF- – в зоне скоплений клеток CD4+. Такой характер корреляционной взаимосвязи свидетельствует о перераспределении макрофагов во второй тип, обладающих ремоделирующим действием на окружающие ткани при потенцирующем участии клеток лимфоидной популяции.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective: to study the immunophenotype of the macrophage population and the mechanisms of their vectorial redistribution in fibrous cavernous pulmonary tuberculosis.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. The material for the study was fragments of the fibrous cavern wall and pericavernous lung tissue of the dead or surgical patients diagnosed with fibrous cavernous tuberculosis (n = 163). All patients were divided into 2 main groups: patients with active bacteria excretion (MTB+, n = 84) and patients with clinical abacillation (MTB–, n = 79) for immunohistochemistry with a panel of markers for: macrophages and histiocytes – CD68; vascular growth factor A – VEGF-A; T-helpers – CD4, and T-cytotoxic lymphocytes – CD8.</p></sec><sec><title>Results</title><p>Results. Following the analysis of CD68 expression, the population heterogeneity of macrophages was revealed depending on the intensity of the cytoplasmic reaction, functional activity, localization and quantitative characteristics. Three groups were identified: highly active, moderately active and weakly active. Based on the reaction with vascular growth factor A, it was determined that VEGF+ cells correspond to weakly active CD68+ macrophages and are located on the border between the specific granulation tissue and fibrous layer as well as in the pericavernous zone and intact lung tissue with a statistically significant predominance in patients with MTB– (p &lt; 0.05). Regardless of the scope of bacterial secretion, the number of VEGF+ cells in the lymphoid follicle zone directly correlates with that of CD68+ macrophages in the pericavernous zone (R = 0.68) and indirectly correlates with the number of diffusely scattered VEGF+ cells in the fibrous capsule (R = –0.75). In the meantime, CD68+/VEGF+ are visualized in the zone of CD8+ T-lymphocytes, and CD68+/VEGF- – in the zone of CD4+ cell clusters. Such correlation indicates the redistribution of macrophages into type 2, which has a remodeling effect on the surrounding tissues with the potentiating participation of lymphoid cells.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>фиброзно-кавернозный туберкулез</kwd><kwd>макрофаги</kwd><kwd>иммунофенотип</kwd><kwd>иммунитет</kwd><kwd>иммуногистохимия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fibrous cavernous pulmonary tuberculosis</kwd><kwd>macrophages</kwd><kwd>immunophenotype</kwd><kwd>immunity</kwd><kwd>immunohistochemistry</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Global Tuberculosis report. 2017.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Global Tuberculosis report. 2017.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Cliff J.M., Kaufmann S.H., McShane H., van Helden P., O’Garra A. The human immune response to tuberculosis and its treatment: a view from the blood. Immunol. Rev. 2015; 264 (1): 88–102.</mixed-citation><mixed-citation xml:lang="en">Cliff J.M., Kaufmann S.H., McShane H., van Helden P., O’Garra A. The human immune response to tuberculosis and its treatment: a view from the blood. Immunol. Rev. 2015; 264 (1): 88–102.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ziuzia Iu.R., Zimina V.N., Al’varesFigeroa M.V., Parkhomenko Iu.G., Dolgova E.A. The morphological characteristics of HIV-associated tuberculosis in relation to blood CD4+ lymphocyte counts. Arkh. Patol. 2014; Sept.-Oct.; 76 (5): 33–37.</mixed-citation><mixed-citation xml:lang="en">Ziuzia Iu.R., Zimina V.N., Al’varesFigeroa M.V., Parkhomenko Iu.G., Dolgova E.A. The morphological characteristics of HIV-associated tuberculosis in relation to blood CD4+ lymphocyte counts. Arkh. Patol. 2014; Sept.-Oct.; 76 (5): 33–37.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bhattacharya D., Danaviah S., Muema D.M., Akilimali N.A., Moodley P., Ndung’u T., Das G. Cellular аrchitecture of spinal granulomas and the immunological response in tuberculosis patients coinfected with HIV. Front. Immunol. 2017; 8: 1120. DOI: 10.3389/fimmu.2017.01120.</mixed-citation><mixed-citation xml:lang="en">Bhattacharya D., Danaviah S., Muema D.M., Akilimali N.A., Moodley P., Ndung’u T., Das G. Cellular аrchitecture of spinal granulomas and the immunological response in tuberculosis patients coinfected with HIV. Front. Immunol. 2017; 8: 1120. DOI: 10.3389/fimmu.2017.01120.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Huygen K. The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis. Front. Immunol. 2014; 5: 1–11.</mixed-citation><mixed-citation xml:lang="en">Huygen K. The immunodominant T-cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis. Front. Immunol. 2014; 5: 1–11.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jasenosky L.D., Scriba T.J., Hanekom W.A., Goldfeld A.E. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol. Rev. 2015; 264: 74–87. pmid: 25703553.</mixed-citation><mixed-citation xml:lang="en">Jasenosky L.D., Scriba T.J., Hanekom W.A., Goldfeld A.E. T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol. Rev. 2015; 264: 74–87. pmid: 25703553.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Rep. 2014; 6: 13. Published 2014 Mar. 3. DOI: 10.12703/P6-13.</mixed-citation><mixed-citation xml:lang="en">Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Rep. 2014; 6: 13. Published 2014 Mar. 3. DOI: 10.12703/P6-13.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Italiani P., Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front. Immunol. 2014; 5: 514. DOI: 10.3389/fimmu.2014.00514.</mixed-citation><mixed-citation xml:lang="en">Italiani P., Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front. Immunol. 2014; 5: 514. DOI: 10.3389/fimmu.2014.00514.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Serena Y.S. Tan, Mark A. Developmental origin of lung macrophage diversity. Krasnow Development. 2016; 143: 1318–1327. DOI: 10.1242/dev.129122.</mixed-citation><mixed-citation xml:lang="en">Serena Y.S. Tan, Mark A. Developmental origin of lung macrophage diversity. Krasnow Development. 2016; 143: 1318–1327. DOI: 10.1242/dev.129122.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Dorhoi A., Kaufmann S.H. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol. 2016; Mar.; 38 (2): 153–166. Epub. 2015, Oct. 5.</mixed-citation><mixed-citation xml:lang="en">Dorhoi A., Kaufmann S.H. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin. Immunopathol. 2016; Mar.; 38 (2): 153–166. Epub. 2015, Oct. 5.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Янин В.Л., Бондаренко О.М., Сазонова Н.А. Методы исследования в цитологии и гистологии: учебнометодическое пособие. Ханты-Мансийск: БУ «ХантыМансийская государственная медицинская академия», 2015: 65.</mixed-citation><mixed-citation xml:lang="en">Yanin V.L., Bondarenko O.M., Sazonova N.A. Methods of research in cytology and histology: teaching guide. Khanty-Mansiysk: BU “Khanty-Mansiysk State Medical Academy” Publ., 2015: 65 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kim P.S., Makhene M., Sizemore C., Hafner R. Viewpoint: Challenges and opportunities in tuberculosis research. J. Infect. Dis. 2012; 205 Suppl. 2: 347–352.</mixed-citation><mixed-citation xml:lang="en">Kim P.S., Makhene M., Sizemore C., Hafner R. Viewpoint: Challenges and opportunities in tuberculosis research. J. Infect. Dis. 2012; 205 Suppl. 2: 347–352.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lyadova I.V., Panteleev A.V. Th1 and Th17 сells in tuberculosis: рrotection, рathology, and biomarkers. Mediators Inflamm. 2015; 2015: 8545–8507.</mixed-citation><mixed-citation xml:lang="en">Lyadova I.V., Panteleev A.V. Th1 and Th17 сells in tuberculosis: рrotection, рathology, and biomarkers. Mediators Inflamm. 2015; 2015: 8545–8507.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Aryanpur M., Mortaz E., Masjedi M.R., Tabarsi P., Garssen J., Adcock I.M., Mozafarian A. and Sharifi H. Reduced phagocytic capacity of blood monocyte/macrophages in tuberculosis patients is further reduced by smoking. Iranian Journal of Allergy, Asthma and Immunology. 2016; 15 (3): 174–182.</mixed-citation><mixed-citation xml:lang="en">Aryanpur M., Mortaz E., Masjedi M.R., Tabarsi P., Garssen J., Adcock I.M., Mozafarian A. and Sharifi H. Reduced phagocytic capacity of blood monocyte/macrophages in tuberculosis patients is further reduced by smoking. Iranian Journal of Allergy, Asthma and Immunology. 2016; 15 (3): 174–182.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Yakar H.I., Gunen H., Pehlivan E., Aydogan S. The role of tuberculosis in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2017; 12: 323–329. DOI: 10.2147/COPD.S116086.</mixed-citation><mixed-citation xml:lang="en">Yakar H.I., Gunen H., Pehlivan E., Aydogan S. The role of tuberculosis in COPD. Int. J. Chron. Obstruct. Pulmon. Dis. 2017; 12: 323–329. DOI: 10.2147/COPD.S116086.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Kim H.J., Baek S., Kim H.J. The impact of smoking on airflow limitation in subjects with history of asthma and inactive tuberculosis. PLoS One. 2015; 10 (4). DOI: 10.1371/journal.pone.0125020.</mixed-citation><mixed-citation xml:lang="en">Kim H.J., Baek S., Kim H.J. The impact of smoking on airflow limitation in subjects with history of asthma and inactive tuberculosis. PLoS One. 2015; 10 (4). DOI: 10.1371/journal.pone.0125020.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Chistiakov D.A., Killingsworth M.C., Myasoedova V.A., Orekhov A.N., Bobryshev Y.V. CD68/macrosialin: not just a histochemical marker. Laboratory Investigation. 2017; 97: 4–13.</mixed-citation><mixed-citation xml:lang="en">Chistiakov D.A., Killingsworth M.C., Myasoedova V.A., Orekhov A.N., Bobryshev Y.V. CD68/macrosialin: not just a histochemical marker. Laboratory Investigation. 2017; 97: 4–13.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon S., Plьddemann A., Martinez Estrada F. Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol. Rev. 2014; 262: 36–55.</mixed-citation><mixed-citation xml:lang="en">Gordon S., Plьddemann A., Martinez Estrada F. Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol. Rev. 2014; 262: 36–55.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Italiani P., Boraschi D. From мonocytes to M1/M2 мacrophages: рhenotypical vs functional differentiation. Front. Immunol. 2014; 5: 514. DOI: 10.3389/fimmu.2014.00514.</mixed-citation><mixed-citation xml:lang="en">Italiani P., Boraschi D. From мonocytes to M1/M2 мacrophages: рhenotypical vs functional differentiation. Front. Immunol. 2014; 5: 514. DOI: 10.3389/fimmu.2014.00514.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Chávez-Galán L., Olleros M.L., Vesin D., Garcia I. Much мore than M1 and M2 мacrophages, there are also CD169(+) and TCR(+) macrophages. Front. Immunol. 2015; 6: 263. DOI: 10.3389/fimmu.2015.00263.</mixed-citation><mixed-citation xml:lang="en">Chávez-Galán L., Olleros M.L., Vesin D., Garcia I. Much мore than M1 and M2 мacrophages, there are also CD169(+) and TCR(+) macrophages. Front. Immunol. 2015; 6: 263. DOI: 10.3389/fimmu.2015.00263.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Голубинская Е.П., Филоненко Т.Г., Кальфа М.А., Ермола Ю.А. Морфологические особенности ангиогенеза при фиброзно-кавернозном туберкулезе. Крымский журнал экспериментальной и клинической медицины. 2018; 8 (1): 16–19.</mixed-citation><mixed-citation xml:lang="en">Golubinskaya E.P., Filonenko T.G., Kalfa M.A., Ermola Yu. A. Morphological features of angiogenesis in fibrous cavernous pulmonary tuberculosis. Crimean Journal of Experimental and Clinical Medicine. 2018; 8 (1): 16–19 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Голубинская Е.П., Крамарь Т.В. Морфофункциональное обоснование таргетной терапии блокаторами ангиогенеза при фиброзно-кавернозном туберкулезе. Материалы международного форума «Биотехнология: состояние и перспективы развития». 2018, май 23–25; Москва, Россия: 400–402.</mixed-citation><mixed-citation xml:lang="en">Golubinskaya E.P., Kramar T.V. Morphofunctional substantiation of targeted therapy with blockers of angiogenesis in fibrous cavernous pulmonary tuberculosis. Materials of the international forum “Biotechnology: state and prospects of development”. 2018, May 23–25; Moscow, Russia: 400–402 (in Russ.).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
